The Technical Analyst
Rapid Micro Biosystems, [RPID]
Exchange: NASDAQ Sector: Healthcare Industry: Medical Devices
Rapid Micro Biosystems, Price, Forecast, Insider, Ratings, Fundamentals & Signals
-0.46% $0.946
America/New_York / 26 apr 2024 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 40.47 mill |
| EPS: | -1.220 |
| P/E: | -0.780 |
| Earnings Date: | May 03, 2024 |
| SharesOutstanding: | 42.79 mill |
| Avg Daily Volume: | 0.0448 mill |
| RATING 2024-04-26 |
|---|
| C+ |
| Sell |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Sell | |
| Return On Equity: | Strong Sell | |
| Return On Asset: | Sell | |
| DE: | Neutral | |
| P/E: | Neutral | |
| Price To Book: | Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -0.780 | sector: PE -3.05 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0.00x |
| Company: PE -0.780 | industry: PE 222.16 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 0.904 - 0.988 ( +/- 4.44%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2024-03-11 | Wilson John J. Addington | Sell | 9 569 | Class A Common Stock |
| 2024-03-11 | Vezina Victoria | Sell | 5 435 | Class A Common Stock |
| 2024-03-11 | Wirtjes Sean M | Sell | 7 454 | Class A Common Stock |
| 2024-03-11 | Spignesi Robert G. Jr. | Sell | 10 323 | Class A Common Stock |
| 2024-02-12 | Wilson John J. Addington | Sell | 5 809 | Class A Common Stock |
| INSIDER POWER |
|---|
| 91.56 |
| Last 96 transactions |
| Buy: 3 823 953 | Sell: 95 953 |
Forecast:
16:00 - $0.946
Live Trading Signals (every 1 min)
Forecast
1: 16:00 - $0.946
Forecast 2: 16:00 - $0.946
Forecast 3: 16:00 - $0.946
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 |
| Volume Signals | |
|---|---|
| Price | $0.946 (-0.46% ) |
| Volume | 0.0050 mill |
| Avg. Vol. | 0.0448 mill |
| % of Avg. Vol | 11.07 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For RPID
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
RPID
Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in North America, Europe, and Asia. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and comprehensive customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides installation and verification, technical training, and support services. Its solutions are used in environmental monitoring, water testing, bioburden, and sterility release testing applications. The company was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007. Rapid Micro Biosystems, Inc. was incorporated in 2006 and is headquartered in Lowell, Massachusetts.
Last 10 Buy Signals
Latest Press Releases
2024-04-18 16:30:00 - Press Release
Rapid Micro Biosystems To Announce First Quarter 2024 Financial Results On May 3, 2024
Lowell, mass., april 18, 2024 (globe newswire) -- rapid micro biosystems, inc. (nasdaq: rpid) (the “company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, will release first quarter 2024 financial results prior to the market open on friday, may 3, 2024.
2024-03-19 16:30:00 - Press Release
Rapid Micro Biosystems To Exhibit At The 2024 Pda Annual Meeting From March 25 - 27, 2024
Company to give technical presentation on its innovative growth direct® rapid sterility application company to give technical presentation on its innovative growth direct® rapid sterility application
2024-03-12 16:50:00 - Press Release
Rapid Micro Biosystems To Participate In The Virtual Keybanc Life Sciences & Medtech Investor Forum
Lowell, mass., march 12, 2024 (globe newswire) -- rapid micro biosystems, inc. (nasdaq: rpid) (the “company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that the company will participate in the virtual keybanc life sciences & medtech investor forum on march 19, 2024.
2024-03-06 18:40:00 - Press Release
Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Lowell, mass., march 06, 2024 (globe newswire) -- rapid micro biosystems, inc. (nasdaq: rpid) (the “company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that, effective march 4, 2024, the compensation committee of the company's board of directors granted non-qualified stock options to purchase 150,000 shares of the company's class a common stock (“common stock”) and 75,000 restricted stock units (“rsus”) to a new employee under the company's 2023 inducement plan, as amended (the “2023 inducement plan”).
2024-03-01 06:30:00 - Press Release
Rapid Micro Biosystems Reports Fourth Quarter And Full Year 2023 Financial Results And Provides 2024 Guidance
Reports fourth quarter 2023 total revenue of $6.3 million , representing 45% growth compared to fourth quarter 2022
Latest News
2024-04-18 16:30:00 - GlobeNewsWire
Rapid Micro Biosystems to Announce First Quarter 2024 Financial Results on May 3, 2024
LOWELL, Mass., April 18, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, will release first quarter 2024 financial results prior to the market open on Friday, May 3, 2024.
2024-03-01 13:31:09 - Seeking Alpha
Rapid Micro Biosystems, Inc. (RPID) Q4 2023 Earnings Call Transcript
2024-02-27 16:30:00 - GlobeNewsWire
Rapid Micro Biosystems to Participate in Upcoming Investor Conferences
LOWELL, Mass., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that the Company will participate in the following investor conferences:
2024-02-20 16:36:00 - GlobeNewsWire
Rapid Micro Biosystems to Announce Fourth Quarter and Full Year 2023 Financial Results on March 1, 2024
LOWELL, Mass., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, will release fourth quarter and full year 2023 financial results prior to the market open on Friday, March 1, 2024.
2024-01-03 07:15:00 - GlobeNewsWire
Rapid Micro Biosystems to Present at 42nd Annual J.P. Morgan Healthcare Conference
LOWELL, Mass., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that the Company will participate in the 42nd Annual J.P. Morgan Healthcare Conference.
2023-11-07 16:15:00 - GlobeNewsWire
Rapid Micro Biosystems to Participate in Upcoming Investor Conferences
LOWELL, Mass., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that the Company will participate in the following investor conferences in New York, NY:
2023-11-03 09:47:21 - Zacks Investment Research
Rapid Micro Biosystems, Inc. (RPID) Reports Q3 Loss, Tops Revenue Estimates
Rapid Micro Biosystems, Inc. (RPID) came out with a quarterly loss of $0.31 per share versus the Zacks Consensus Estimate of a loss of $0.32. This compares to loss of $0.38 per share a year ago.
2023-10-19 16:15:00 - GlobeNewsWire
Rapid Micro Biosystems to Announce Third Quarter 2023 Financial Results on November 3, 2023
LOWELL, Mass., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, will release third quarter 2023 financial results prior to the market open on Friday, November 3, 2023.
2023-09-06 16:15:00 - GlobeNewsWire
Rapid Micro Biosystems to Participate in the Morgan Stanley 21st Annual Global HealthCare Conference
LOWELL, Mass., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that the Company will participate in the Morgan Stanley 21st Annual Global Healthcare Conference.
2023-08-04 14:24:09 - Seeking Alpha
Rapid Micro Biosystems, Inc. (RPID) Q2 2023 Earnings Call Transcript
Rapid Micro Biosystems, Inc. (NASDAQ:RPID ) Q2 2023 Earnings Call Transcript August 4, 2023 8:30 AM ET Company Participants Mike Beaulieu - Vice President of Investor Relations Rob Spignesi - CEO, President and Director Sean Wirtjes - Chief Financial Officer Conference Call Participants Yuko Oku - Morgan Stanley Dan Arias - Stifel Operator Ladies and gentlemen, thank you for standing by, and welcome to Rapid Micro Biosystems' Q2 2023 Earnings Call. [Operator Instructions] I would now like to turn the conference over to Mike Beaulieu.